News and Announcements
Folkestone Enters Agreement to Acquire Land From BWP Trust
- Published June 02, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Folkestone (ASX: FLK) is pleased to announce it has entered into agreements with BWP Trust to acquire 1.0 hectare of land and a new call option to acquire an adjoining further 2.4 hectares of land at Millers Road, Altona North, to undertake Stage 3 of its successful Millers Junction project.
Folkestone’s Head of Real Estate Ben Dodwell said “We are pleased to have reached agreement with BWP Trust and Woolworths Supermarkets to enable us to deliver Millers Junction Retail. This, together with Millers Junction Business 2, will deliver the final stage of the Millers Junction masterplan and demonstrates our ability to use our balance sheet to secure and develop investment grade real estate across multiple sectors. This has enabled us to grow our retail development pipeline, which now includes two neighbourhood centres, and has a combined end value of circa $105 million and our enterprise park pipeline which has a combined end value of circa $160 million.”
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
